The benefits of influenza vaccination in patients with cardiovascular disease: a systematic review and meta-analysis
The influenza vaccination provided significant benefits in reducing ACM and MACE. However, it failed to demonstrate advantage in managing HF, MI, and non-cardiovascular death in patients with CVD. Additionally, the high-dose influenza vaccination strategy did not present efficacy in preventing adverse outcomes of CVD compared to the standard strategy.
Authors
- Yehan Li
- Kaiyu Zhou (ORCID: https://orcid.org/0000-0001-6788-9711)
- Meng Wei (ORCID: https://orcid.org/0009-0004-5765-7414)
- Lei Liu
Institutions
- Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-20
- DOI
- https://doi.org/10.3389/fphar.2025.1701127
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 31.52
Funders
- National Natural Science Foundation of China